skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update

Canadian pharmacists journal, 2018-01, Vol.151 (1), p.33-42 [Peer Reviewed Journal]

The Author(s) 2017 ;The Author(s) 2017 2017 Canadian Pharmacists Association ;ISSN: 1715-1635 ;EISSN: 1913-701X ;DOI: 10.1177/1715163517743525 ;PMID: 29317935

Full text available

Citations Cited by
  • Title:
    Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update
  • Author: Lamb, Sarah A. ; Al Hamarneh, Yazid N. ; Houle, Sherilyn K. D. ; Leung, Alexander A. ; Tsuyuki, Ross T.
  • Subjects: Blood pressure ; Chronic illnesses ; Cost control ; Hypertension ; Medical diagnosis ; Patients ; Pharmacists ; Research and Clinical ; Systematic review
  • Is Part Of: Canadian pharmacists journal, 2018-01, Vol.151 (1), p.33-42
  • Description: Changes to 2017 Hypertension Canada guidelines relevant to pharmacists Assess adherence to therapy at every patient encounter Use a multidisciplinary team approach, including work-site health care providers, to improve adherence Evidence for pharmacist-led interventions The pharmacists’ role in chronic disease management is becoming increasingly prominent as a result of an expanded scope of practice and the growing strain on the health care system. A systematic review and meta-analysis of 39 randomized controlled trials comprising over 14,000 patients showed that pharmacists’ interventions—namely, patient education, recommendations to physicians and medication management—resulted in greater reductions of both SBP (−7.6 mmHg; 95% CI, –9 to −6.3) and DBP (−3.9 mmHg; 95% CI, −5.1 to −2.8) compared with usual care.9 Interestingly, the most pronounced effect on blood pressure reduction was seen when the pharmacist led the intervention, resulting in a SBP reduction of –8.5 mmHg and a DBP reduction of –4.6 mmHg. Results from the RxACTION trial demonstrated an even greater effect on blood pressure reduction when pharmacist interventions included independent prescribing for hypertension (mean SBP reduction 18.3 mmHg, adjusted difference 6.6 mmHg).10 In addition, patients in the pharmacist prescribing arm were 2.3 times more likely to achieve target blood pressures.
  • Publisher: Los Angeles, CA: SAGE Publications
  • Language: English;French
  • Identifier: ISSN: 1715-1635
    EISSN: 1913-701X
    DOI: 10.1177/1715163517743525
    PMID: 29317935
  • Source: NCBI PubMed Central（免费）
    ProQuest Central
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait